Guanosine Mechanisms of Action: Toward Molecular Targets
Overview
Affiliations
Tasca C, Zuccarini M, Di Iorio P, Ciruela F Purinergic Signal. 2024; .
PMID: 39004650 DOI: 10.1007/s11302-024-10033-y.
Merino-Gomez M, Godoy-Gallardo M, Wendner M, Mateos-Timoneda M, Gil F, Perez R Front Bioeng Biotechnol. 2023; 11:1147943.
PMID: 37020512 PMC: 10069680. DOI: 10.3389/fbioe.2023.1147943.
Purinergic signaling: A gatekeeper of blood-brain barrier permeation.
Wang Y, Zhu Y, Wang J, Dong L, Liu S, Li S Front Pharmacol. 2023; 14:1112758.
PMID: 36825149 PMC: 9941648. DOI: 10.3389/fphar.2023.1112758.
Zuccarini M, Pruccoli L, Balducci M, Giuliani P, Caciagli F, Ciccarelli R J Clin Med. 2023; 12(3).
PMID: 36769818 PMC: 9917437. DOI: 10.3390/jcm12031172.
Guanine inhibits the growth of human glioma and melanoma cell lines by interacting with GPR23.
Garozzo R, Zuccarini M, Giuliani P, Di Liberto V, Mudo G, Caciagli F Front Pharmacol. 2022; 13:970891.
PMID: 36199684 PMC: 9527276. DOI: 10.3389/fphar.2022.970891.